When a lab report shows elevated ALT or AST, the clinical note may use the word transaminitis. That wording is common in everyday medical communication, but coding requires a more exact description of the finding. For many outpatient encounters, the key question is whether the provider has documented only elevated liver transaminase levels or has already confirmed the condition causing them. This distinction matters because the code should match what is known and documented at the time of the visit.
For ICD transaminitis coding, R74.01 is the ICD 10 CM code used for elevation of liver transaminase levels. The code describes the abnormal laboratory finding rather than a specific liver disease. It can be useful when ALT, AST, or both are elevated and the provider has not yet established a final cause. Once the medical record confirms a specific condition, the coding may need to change so the diagnosis reflects the established disease rather than only the abnormal lab result.
This guide explains R74.01 in simple terms, discusses related abnormal enzyme codes, and shows why documentation is important for clean claims. It is written for healthcare practices, billing teams, coders, and anyone who wants a clearer understanding of how elevated liver enzymes may appear in medical billing.
What Does Transaminitis Mean?
Transaminitis is a clinical term used when blood tests show higher than normal levels of transaminase enzymes. The two enzymes most often discussed are alanine aminotransferase, known as ALT, and aspartate aminotransferase, known as AST. These enzymes are present inside cells. When cells become irritated or injured, the enzymes can enter the blood and the measured level can rise.
ALT is closely associated with the liver, while AST can also come from other tissues. For this reason, an elevated AST result by itself does not always point to one specific liver condition. Providers usually look at the full clinical picture, including symptoms, medical history, medications, alcohol use, metabolic risk, other laboratory results, and imaging when needed.
Transaminitis does not tell the provider why the enzymes are elevated. It describes a finding. The cause may later turn out to be a liver condition, medication effect, infection, metabolic condition, muscle problem, or another issue. That is why coding should follow the level of certainty documented in the record rather than assume a diagnosis that has not been confirmed.
Understanding ICD Transaminitis and R74.01
The most important point in ICD transaminitis coding is that the code set describes the measurable finding as elevation of liver transaminase levels. R74.01 is the specific code for this finding. The Centers for Medicare and Medicaid Services lists R74.01 as “Elevation of levels of liver transaminase levels” in the current ICD 10 CM definitions. This makes R74.01 the direct code to review when the documented problem is elevated liver transaminases without a confirmed underlying diagnosis.
A coder should still read the complete note before assigning the code. If the provider documents a confirmed liver disease or another condition that explains the abnormal enzymes, the established diagnosis may be more appropriate. If the encounter is focused on investigating unexplained elevated ALT or AST, R74.01 may accurately represent the reason for the evaluation.
The code should never replace clear documentation. A note that simply says abnormal labs may not provide enough detail. The assessment should identify the elevated liver transaminases when that is the finding being evaluated. Clear wording helps the coding team connect the provider assessment, planned workup, and claim diagnosis.
Why R74.01 Is Used for Elevated Liver Transaminases
R74.01 belongs to the group of codes used for abnormal serum enzyme levels. Its wording is specific to liver transaminases, which makes it more precise than a broad abnormal enzyme code when ALT and AST are the findings under review.
A common situation occurs after routine blood work. A patient may feel well and have no established liver diagnosis, yet the ALT and AST values are above the laboratory reference range. The provider may repeat the hepatic panel, review medications, discuss alcohol use, order additional laboratory testing, or request imaging. At this stage, the medical record may support an abnormal finding code because the evaluation is still in progress.
The coding can change later. If testing confirms a specific disease, the provider should document that diagnosis clearly. The billing team can then code the confirmed condition according to the record. This keeps the claim aligned with the patient’s current clinical status and avoids leaving a temporary finding code in place after the cause becomes known.
ICD 10 Code for Elevated ALT
People often search for the phrase icd 10 code for elevated alt when they see an abnormal ALT result in the chart. When the provider documents elevated liver transaminase levels and no more specific diagnosis has been established, R74.01 is the code that directly describes that finding. ALT is a liver transaminase, so the wording of R74.01 fits this type of documented elevation.
However, coding should not rely on a single lab number without context. The provider should review the result and document the clinical assessment. The record should make clear whether the visit is addressing elevated transaminases, a confirmed liver disease, a medication effect, or another known condition. The code follows that documented assessment.
If ALT is elevated together with AST, R74.01 may still describe the finding when the cause remains unknown. If a confirmed diagnosis explains the abnormal values, the disease code may become the better choice. Accurate coding starts with the provider’s documented conclusion, not with a search term or an isolated laboratory value.
ALT and AST: Why Both Matter
ALT and AST are commonly reviewed together because the pattern can give the provider useful clinical information. ALT is found mainly in the liver. AST is also present in muscle and other tissues. A rise in both enzymes can support further evaluation, but the values alone do not establish the exact cause.
The provider may compare current results with earlier tests to see whether the levels are improving, stable, or rising. The provider may also review bilirubin, alkaline phosphatase, albumin, symptoms, medication use, and other findings. This wider view helps determine whether the patient needs repeat testing, additional workup, or treatment for a known condition.
For billing purposes, the diagnosis on the claim should match the reason for the service and the assessment in the note. When elevated transaminases are the active problem being evaluated, R74.01 can communicate that finding clearly. When the record identifies a more specific disease, the coding should reflect that greater level of certainty.
Diagnosis Code R74.8 and How It Differs
The phrase diagnosis code r74.8 refers to abnormal levels of other serum enzymes. It is a valid code, but it does not mean the same thing as R74.01. R74.01 specifically describes elevation of liver transaminase levels, while R74.8 is used for other abnormal serum enzyme findings that are not better described by a more specific code.
This difference matters because coding should use the most accurate description supported by the medical record. If the provider clearly documents elevated ALT or AST as the problem, R74.01 is more specific to liver transaminase elevation. Using a broad code when a specific code fits the documented finding can make the claim less clear.
R74.8 may still be appropriate in the right clinical situation. The deciding factor is the enzyme involved and the provider’s documentation. Coders should avoid choosing R74.8 simply because the note uses a general phrase such as elevated enzymes. They should review the actual assessment and available lab information to determine what the provider is addressing.
Transaminitis ICD 10 Code and Documentation
A search for transaminitis icd 10 code usually leads to R74.01 because ICD 10 CM describes the finding as elevated liver transaminase levels. Good documentation should connect that finding to the care provided during the encounter. This connection helps the coder understand why testing, follow up, or other services were medically necessary.
The assessment can state that ALT and AST are elevated and that the cause has not yet been established. The plan can then explain what the provider will do next. For example, the provider may repeat a hepatic function panel, review medications and supplements, order viral hepatitis testing, consider imaging, or schedule follow up based on the clinical picture.
The record should also be updated when the situation changes. If the workup later confirms a specific liver condition, the assessment should name it. Keeping the problem list and encounter diagnosis current helps the billing team avoid continuing to use R74.01 after a more specific diagnosis has been established.
Common Reasons for Elevated Liver Enzymes
Elevated liver enzymes can have many causes, so the finding should not be treated as a diagnosis by itself. Providers may consider metabolic conditions, alcohol related liver injury, viral hepatitis, medication effects, supplements, and other liver disorders. Some non liver conditions can also affect AST and other enzyme results.
The purpose of the workup is to identify the cause when possible. A provider may ask about recent illness, alcohol intake, prescription medicines, over the counter medicines, supplements, weight changes, metabolic risk, and possible exposure to viral hepatitis. The provider may also order additional blood tests or imaging based on the patient’s history and results.
From a coding point of view, this process shows why R74.01 can be useful during the evaluation stage. It communicates the known abnormal finding without assigning an unconfirmed disease. Once the cause is established, the medical record should move from the finding to the confirmed diagnosis when appropriate.
When R74.01 May Be Appropriate
R74.01 may be appropriate when elevated liver transaminase levels are documented and the provider has not established a more specific diagnosis. This often happens during an initial evaluation or follow up visit after abnormal laboratory results.
The code may also appear when the provider is monitoring unexplained ALT and AST elevation over time. The medical record should show that the abnormality is clinically relevant and that the provider is evaluating or managing it. A diagnosis code should not be added only because a laboratory value appears outside the reference range. The provider’s assessment gives the result its clinical meaning.
In outpatient coding, signs, symptoms, and abnormal findings can be reported when a related definitive diagnosis has not been established. That principle supports the use of a finding code such as R74.01 when the documented reason for the encounter is the unexplained elevation itself.
When a More Specific Diagnosis May Be Needed
R74.01 should not become a permanent label when the provider later identifies the cause of the abnormal enzymes. If the patient receives a confirmed diagnosis, the claim should reflect that diagnosis when it is the condition being evaluated or treated.
For example, a completed workup may identify a specific liver disease or another medical condition responsible for the abnormal results. At that point, the provider should document the confirmed condition in the assessment. The coder can then select the code that matches the established diagnosis.
This approach improves accuracy because the claim follows the patient’s clinical story. Early in the workup, the known fact may be elevated transaminases. Later, the known fact may be a diagnosed disease. Coding should change as the level of clinical certainty changes.
Documentation That Supports R74.01
Clear documentation makes coding easier and gives the claim a stronger connection to the service performed. The provider should identify the abnormal finding in the assessment rather than rely only on the laboratory report. Including the relevant ALT and AST results can add useful context, especially when the visit focuses on reviewing abnormal laboratory values.
The plan should show how the provider intends to evaluate or manage the finding. Repeat testing, medication review, additional laboratory studies, imaging, and follow up can all be documented when clinically appropriate. The exact plan depends on the patient and should come from the treating provider.
Avoid vague wording when a more precise statement is available. Phrases such as abnormal labs or abnormal liver tests may not tell the coding team which finding is being addressed. Naming elevated liver transaminases gives a clearer link to R74.01 and helps keep the assessment, plan, and claim consistent.
How Coding Errors Can Lead to Claim Problems
A claim can face problems even when the selected diagnosis code exists and is billable. Payers also look at whether the diagnosis supports the service, whether the documentation matches the claim, and whether coverage rules are met.
One common issue is using a broad abnormal enzyme code when the note clearly identifies elevated liver transaminases. Another is continuing to report R74.01 after the provider has confirmed a specific diagnosis. A third issue occurs when the claim includes R74.01 but the note does not clearly document the elevated transaminase finding or the reason for further testing.
Billing teams can reduce these problems by reviewing the assessment and plan together. The diagnosis should describe the condition or finding that the provider actually addressed. The ordered services should connect logically to that assessment. This simple alignment can make the claim easier to understand and defend.
R74.01 and Medical Necessity
A valid diagnosis code does not guarantee payment. Medical necessity depends on the service performed, the patient’s condition, payer policy, and the documentation in the record. Different payers may have different coverage rules for laboratory tests, imaging, and follow up services.
For this reason, practices should avoid treating R74.01 as a universal payment code. The provider should document why the patient needs the ordered service. If the plan includes repeat testing or additional evaluation, the note should connect that plan to the elevated liver transaminases and the patient’s clinical situation.
The Centers for Medicare and Medicaid Services includes R74.01 among diagnosis codes used in coverage materials for hepatic function testing and other liver related services. Practices can review the official CMS Medicare Coverage Database for current coverage information and should also verify the rules of the patient’s specific payer.
Also Read: Improve Accuracy Across Medical Billing
Accurate diagnosis coding is only one part of a clean revenue cycle. Eligibility, documentation, charge capture, coding review, claim submission, denial management, and follow up all affect how quickly a practice receives payment. Practices that build clear workflows around these steps can reduce avoidable rework and make claim follow up easier.
When reviewing other coding topics, use the same basic rule: code what the provider documents, choose the most specific supported code, and update the diagnosis when the clinical picture becomes clearer. This approach helps keep medical records and claims aligned.
Need a Smarter Way to Manage Coding and Claims?
Xoodoc uses intelligent revenue cycle workflows to help healthcare teams improve billing accuracy, identify claim risks, and reduce avoidable rework. Smarter billing starts with better information and cleaner processes.
Learn more at xoodoc.com
Practical Coding Review Before Claim Submission
Before submitting a claim that includes R74.01, confirm that the provider assessment clearly identifies elevated liver transaminase levels. Check that the note supports the reason for any testing or follow up. Make sure a confirmed diagnosis has not already replaced the abnormal finding. Review the claim for consistency between the diagnosis, service, and documentation. These simple checks can prevent avoidable confusion and support a cleaner billing process.
Why Accurate Transaminitis Coding Matters for Revenue Cycle Management
Accurate coding supports more than compliance. It also helps the revenue cycle move with fewer interruptions. When the diagnosis accurately reflects the documented reason for care, billing teams spend less time trying to understand unclear claims or correcting mismatched information.
R74.01 is a good example of why specificity matters. The code describes a particular laboratory finding. Using it when the documentation supports elevated liver transaminases gives the payer a clearer picture than a vague abnormal enzyme code. At the same time, replacing it when a definitive diagnosis becomes known prevents the record from staying stuck at an earlier stage of the patient’s evaluation.
Strong revenue cycle management depends on this kind of attention to detail. Providers document the clinical picture, coders translate that documentation into the correct code, and billing teams submit a claim that accurately represents the service. Each step supports the next one.
The Key Point About ICD Transaminitis Coding
The main rule is simple. ICD transaminitis coding should reflect what the provider knows and documents at the time of the encounter. When the documented finding is elevated liver transaminase levels without a confirmed cause, R74.01 is the specific ICD 10 CM code to review. When the provider confirms a disease or another condition that explains the finding, coding should move to the established diagnosis when appropriate.
Practices should also remember that accurate coding and payment are not the same thing. A code can be valid while a payer still requires specific medical necessity, documentation, or coverage criteria. Clear notes, current diagnoses, and careful claim review remain essential.
By keeping the assessment, plan, diagnosis code, and billed service aligned, healthcare teams can reduce preventable claim problems and maintain a cleaner revenue cycle.
Official ICD 10 CM Reference
For an official coding reference, review the CMS ICD 10 CM FY 2026 definitions, which lists R74.01 as elevation of levels of liver transaminase levels.
Frequently Asked Questions
R74.01 is the ICD 10 CM code for elevation of liver transaminase levels. It may be used when elevated ALT or AST is documented and no more specific diagnosis has been established.
Yes. R74.01 is a specific ICD 10 CM diagnosis code. Payment still depends on the service, payer policy, medical necessity, and supporting documentation.
R74.01 describes elevation of liver transaminase levels, which includes ALT. The provider should document the finding and the clinical assessment rather than relying only on the laboratory result.
R74.01 specifically describes elevated liver transaminase levels. R74.8 describes abnormal levels of other serum enzymes. The code should match the enzyme finding documented by the provider.
A confirmed diagnosis may require a more specific disease code. Coding should follow the provider’s current documentation and the reason for the encounter.
No. A valid diagnosis code does not guarantee reimbursement. Coverage depends on payer rules, the billed service, medical necessity, and the documentation in the medical record.
Clear documentation tells the coder which finding or condition the provider is evaluating. It also connects the diagnosis to testing, follow up, and other services on the claim.
